Watch NUMD. Know when insiders buy.
One email the day a filing lands. Free.
NUMD
Nu-Med Plus, Inc.
0.02
+0.00 +0.00%
USD · close Sep 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.9MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$56KNET CASH $2K52W 0.01 – 0.04SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $0 | — | — | −$23K | $20K | — | 0.00 | $1K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $0 | — | — | −$13K | −$16K | — | 0.00 | −$6K | — | — | Aug 14 |
| Q2 2025 · Jun 30 | $0 | — | — | −$10K | −$12K | — | 0.00 | −$2K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $0 | — | — | −$19K | −$20K | — | 0.00 | $0 | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | — | — | — | −$9K | −$11K | — | 0.00 | −$2K | — | — | Apr 15 |
| Q3 2024 · Sep 30 | — | — | — | −$17K | −$19K | — | 0.00 | — | — | — | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | — | −$17K | — | — | — | — | — | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | −$21K | −$22K | — | 0.00 | −$450 | — | — | Nov 14 |
| Q4 2023 · Dec 31derived | — | — | — | −$55K | −$57K | — | 0.00 | −$4K | — | — | Mar 31 |
| Q3 2023 · Sep 30 | — | — | — | −$15K | −$16K | — | 0.00 | −$19K | — | — | Nov 14 |
| Q2 2023 · Jun 30 | — | — | — | −$23K | −$24K | — | 0.00 | −$23K | — | — | Nov 14 |
| Q1 2023 · Mar 31 | — | — | — | −$27K | −$28K | — | 0.00 | −$20K | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$49K | −$56K | — | 0.00 | −$48K | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$63K | −$68K | — | 0.00 | −$4K | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$121K | −$126K | — | 0.00 | −$66K | — | — | — | — |
| FY2022 · to Dec 31 | — | — | −$182K | −$130K | — | 0.00 | −$38K | — | — | — | — |
| FY2021 · to Dec 31 | — | — | −$839K | −$830K | — | -0.01 | −$207K | — | — | — | — |
| FY2020 · to Dec 31 | $0 | — | −$2M | −$2M | — | -0.04 | −$415K | — | — | — | — |
Every number comes from Nu-Med Plus, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.